(Reuters) - Valeant Pharmaceuticals is reaching out to potential buyers for its specialty contact lens manufacturing division, Paragon Vision Sciences, amid scrutiny from the Federal Trade Commission, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results